Cochrane Abstracts
Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Short Acting Beta2‐agonist Use in Chronic Asthma: Regular Versus as Needed Treatment." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2���agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment. Accessed 03 December 2023.
Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2���agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment. Accessed December 3, 2023.
Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2���agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment
Inhaled Short Acting Beta2‐agonist Use in Chronic Asthma: Regular Versus as Needed Treatment [Internet]. In: Cochrane Abstracts. [cited 2023 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2���agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment
ID - 434045
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434045/all/Inhaled_short_acting_beta2���agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment
DB - Evidence Central
DP - Unbound Medicine
ER -
